¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"thyroid stimulating antibody"¿¡ ´ëÇÑ ´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
interstitial cell-stimulating hormone
°£Áú¼¼Æ÷(Êàòõá¬øà)ÀÚ±Ø(í©Ð½) È£¸£¸ó
melanocyte-stimulating hormone
¸á¶ó´Ñ¼¼Æ÷ÀÚ±Ø(á¬øàí©Ð½) È£¸£¸ó
melanocyte-stimulating hormone regulatory hormone
¸á¶ó´Ñ¼¼Æ÷ÀÚ±Ø(á¬øàí©Ð½) È£¸£¸ó Á¶Àý(ðàï½) È£¸£¸ó
melanocyte-stimulating hormone rease-inhibiting hormone
¸Þ¶ó´Ñ¼¼Æ÷ÀÚ±Ø(á¬øàí©Ð½) È£¸£¸ó À¯¸® ÀúÇØ(ë´×îîÁúª) È£¸£¸ó
melanocyte-stimulating hormone releasing hormone
¸Þ¶ó´Ñ¼¼Æ÷ÀÚ±Ø(á¬øàí©Ð½) È£¸£¸ó À¯¸®(ë´×î) È£¸£¸ó
acquired antibody
"ȹµæÇ×ü (üòÔðù÷ô÷), ÈÄõ¼ºÇ×ü (ýô¸àõù÷ô÷)"
agglutinating antibody
ÀÀÁýÇ×ü(ëêó¢ù÷ô÷)
anti-idiotype antibody
Ç×(ù÷)À̵ð¿ÀŸÀÌÇÁ Ç×ü(ù÷ô÷)
anti-immunoglobulin antibody
Ç׸鿪(ù÷Øóæ¹)±Û·ÎºÒ¸° Ç×ü(ù÷ô÷)
antibody
Ç×ü(ù÷ô÷)
antibody binding fraction
Ç×ü°áÇÕºÐȹ (ù÷ô÷Ì¿ùêÝÂüò)
antibody combining site
Ç×ü°áÂø(ù÷ô÷Ì¿ó·)ÀÚ¸®
antibody dependent cellular cytotoxicity
Ç×üÀÇÁ¸ÀÚ¸® ¼¼Æ÷¼º¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øààõá¬øàÔ¸àõ)
antibody diversity
Ç×ü ´Ù¾ç¼º(ù÷ô÷ÒýåÆàõ)
antibody fixation
Ç×ü °íÁ¤(ù÷ô÷ͳïÒ)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½